Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Race Oncology Ltd. ( (AU:RAC) ) is now available.
Race Oncology Ltd has announced a proposed issue of 1,139,028 ordinary fully paid securities, with the issue date set for December 10, 2025. This move is part of a placement or other type of issue, which could potentially impact the company’s market positioning and stakeholder interests by increasing its capital base.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies.
Average Trading Volume: 549,495
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$514.1M
For detailed information about RAC stock, go to TipRanks’ Stock Analysis page.